Pathogenetix

Next month, Toxic Reports plans to fully launch the pathogen identification platform developed by PathoGenetix, which went belly up in the summer. 

NEW YORK (GenomeWeb) – PathoGenetix has filed for Chapter 7 bankruptcy in US Bankruptcy Court District of Massachusetts.

NEW YORK (GenomeWeb News) – PathoGenetix said today that it has tapped Sparton to design and manufacture pre-commercial instruments for its Resolution Microbial Genotyping System for detecting microbial pathogens in food.

NEW YORK (GenomeWeb News) – PathoGenetix today said that Marshfield Food Safety will evaluate and provide feedback on PathoGenetix's Resolution Microbial Genotyping System.

NEW YORK (GenomeWeb News) – PathoGenetix today announced it has secured $10 million in Series C financing to further commercialization efforts for its Genome Sequence Scanning technology.

NEW YORK (GenomeWeb News) – Sequencing technology firm PathoGenetix has raised $3.6 million, it said in a regulatory filing.

This article was originally published Oct. 7.

NEW YORK (GenomeWeb News) – PathoGenetix and the US Department of Agriculture's Agricultural Research Service announced late on Monday the evaluation of PathoGenetix's technology for identifying strains of Shiga-toxin-producing E. coli, or STECs, and Salmonella enterica.

NEW YORK (GenomeWeb News) – PathoGenetix and Applied Maths today announced a deal to integrate each other's technologies into a solution for rapid pathogen strain typing.

Pages

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.